NEOVOLTA INC (NEOV) Stock Fundamental Analysis

NASDAQ:NEOV • US6406551068

2.89 USD
-0.15 (-4.93%)
At close: Feb 27, 2026
2.92 USD
+0.03 (+1.04%)
After Hours: 2/27/2026, 8:22:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NEOV. NEOV was compared to 91 industry peers in the Electrical Equipment industry. The financial health of NEOV is average, but there are quite some concerns on its profitability. NEOV is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NEOV had negative earnings in the past year.
  • NEOV had a negative operating cash flow in the past year.
  • In the past 5 years NEOV always reported negative net income.
  • NEOV had a negative operating cash flow in each of the past 5 years.
NEOV Yearly Net Income VS EBIT VS OCF VS FCFNEOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

  • NEOV has a Return On Assets of -97.70%. This is amonst the worse of the industry: NEOV underperforms 83.52% of its industry peers.
  • NEOV has a Return On Equity of -197.52%. This is in the lower half of the industry: NEOV underperforms 64.84% of its industry peers.
Industry RankSector Rank
ROA -97.7%
ROE -197.52%
ROIC N/A
ROA(3y)-54.67%
ROA(5y)-107.82%
ROE(3y)-87.98%
ROE(5y)-145.64%
ROIC(3y)N/A
ROIC(5y)N/A
NEOV Yearly ROA, ROE, ROICNEOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • NEOV has a Gross Margin of 19.05%. This is in the lower half of the industry: NEOV underperforms 60.44% of its industry peers.
  • In the last couple of years the Gross Margin of NEOV has grown nicely.
  • The Profit Margin and Operating Margin are not available for NEOV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y8.41%
NEOV Yearly Profit, Operating, Gross MarginsNEOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The number of shares outstanding for NEOV has been increased compared to 1 year ago.
  • The number of shares outstanding for NEOV has been increased compared to 5 years ago.
  • The debt/assets ratio for NEOV is higher compared to a year ago.
NEOV Yearly Shares OutstandingNEOV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
NEOV Yearly Total Debt VS Total AssetsNEOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • NEOV has an Altman-Z score of 8.10. This indicates that NEOV is financially healthy and has little risk of bankruptcy at the moment.
  • NEOV's Altman-Z score of 8.10 is amongst the best of the industry. NEOV outperforms 91.21% of its industry peers.
  • A Debt/Equity ratio of 0.13 indicates that NEOV is not too dependend on debt financing.
  • NEOV has a better Debt to Equity ratio (0.13) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 8.1
ROIC/WACCN/A
WACCN/A
NEOV Yearly LT Debt VS Equity VS FCFNEOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • A Current Ratio of 2.10 indicates that NEOV has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.10, NEOV is doing good in the industry, outperforming 61.54% of the companies in the same industry.
  • NEOV has a Quick Ratio of 1.60. This is a normal value and indicates that NEOV is financially healthy and should not expect problems in meeting its short term obligations.
  • NEOV's Quick ratio of 1.60 is fine compared to the rest of the industry. NEOV outperforms 65.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.6
NEOV Yearly Current Assets VS Current LiabilitesNEOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • NEOV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -192.43%.
  • Looking at the last year, NEOV shows a very strong growth in Revenue. The Revenue has grown by 615.31%.
  • NEOV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.20% yearly.
EPS 1Y (TTM)-192.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-220%
Revenue 1Y (TTM)615.31%
Revenue growth 3Y23.53%
Revenue growth 5Y33.2%
Sales Q2Q%-2.21%

3.2 Future

  • NEOV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.40% yearly.
  • The Revenue is expected to grow by 65.08% on average over the next years. This is a very strong growth
EPS Next Y26.33%
EPS Next 2Y12.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year156.25%
Revenue Next 2Y65.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NEOV Yearly Revenue VS EstimatesNEOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
NEOV Yearly EPS VS EstimatesNEOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NEOV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NEOV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEOV Price Earnings VS Forward Price EarningsNEOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEOV Per share dataNEOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • NEOV's earnings are expected to grow with 12.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NEOV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEOVOLTA INC

NASDAQ:NEOV (2/27/2026, 8:22:44 PM)

After market: 2.92 +0.03 (+1.04%)

2.89

-0.15 (-4.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-13
Earnings (Next)N/A
Inst Owners22.64%
Inst Owner Change6.14%
Ins Owners14.16%
Ins Owner Change0%
Market Cap110.69M
Revenue(TTM)18.06M
Net Income(TTM)-9.88M
Analysts43.33
Price Target7.65 (164.71%)
Short Float %6.92%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-145.1%
Min EPS beat(2)-292.16%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-169.61%
Min EPS beat(4)-390.2%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)77.14%
Min Revenue beat(2)3.52%
Max Revenue beat(2)150.75%
Revenue beat(4)4
Avg Revenue beat(4)78.34%
Min Revenue beat(4)3.52%
Max Revenue beat(4)150.75%
Revenue beat(8)5
Avg Revenue beat(8)16.99%
Revenue beat(12)6
Avg Revenue beat(12)-1.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-166.67%
EPS NQ rev (3m)-166.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)29.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.13
P/FCF N/A
P/OCF N/A
P/B 22.13
P/tB 29.87
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.47
BVpS0.13
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -97.7%
ROE -197.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.05%
FCFM N/A
ROA(3y)-54.67%
ROA(5y)-107.82%
ROE(3y)-87.98%
ROE(5y)-145.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y8.41%
F-Score3
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.6
Altman-Z 8.1
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-192.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-220%
EPS Next Y26.33%
EPS Next 2Y12.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)615.31%
Revenue growth 3Y23.53%
Revenue growth 5Y33.2%
Sales Q2Q%-2.21%
Revenue Next Year156.25%
Revenue Next 2Y65.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-150.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-318.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-292.65%
OCF growth 3YN/A
OCF growth 5YN/A

NEOVOLTA INC / NEOV FAQ

What is the ChartMill fundamental rating of NEOVOLTA INC (NEOV) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NEOV.


What is the valuation status for NEOV stock?

ChartMill assigns a valuation rating of 0 / 10 to NEOVOLTA INC (NEOV). This can be considered as Overvalued.


What is the profitability of NEOV stock?

NEOVOLTA INC (NEOV) has a profitability rating of 1 / 10.


Can you provide the financial health for NEOV stock?

The financial health rating of NEOVOLTA INC (NEOV) is 4 / 10.